271 related articles for article (PubMed ID: 28391584)
1. The effect of PPARγ agonist on SGLT2 and glucagon expressions in alpha cells under hyperglycemia.
Kim M; Lee EJ; Shin HM; Jung HS; Kim TK; Kim TN; Kwon MJ; Lee SH; Rhee BD; Park JH
J Endocrinol Invest; 2017 Oct; 40(10):1069-1076. PubMed ID: 28391584
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
Lee YJ; Han HJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
Zhou YB; Zhang J; Peng DQ; Chang JR; Cai Y; Yu YR; Jia MZ; Wu W; Guan YF; Tang CS; Qi YF
Cell Biochem Biophys; 2013 Jul; 66(3):421-9. PubMed ID: 23274912
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia enhances adipogenic induction of lipid accumulation: involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and peroxisome proliferator-activated receptor gamma signaling.
Chuang CC; Yang RS; Tsai KS; Ho FM; Liu SH
Endocrinology; 2007 Sep; 148(9):4267-75. PubMed ID: 17540722
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
Bonner C; Kerr-Conte J; Gmyr V; Queniat G; Moerman E; Thévenet J; Beaucamps C; Delalleau N; Popescu I; Malaisse WJ; Sener A; Deprez B; Abderrahmani A; Staels B; Pattou F
Nat Med; 2015 May; 21(5):512-7. PubMed ID: 25894829
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pancreatic beta cells and alpha cells under hyperglycemia: Inverse coupling in pAkt-FoxO1.
Kim MK; Shin HM; Jung H; Lee E; Kim TK; Kim TN; Kwon MJ; Lee SH; Rhee BD; Park JH
Diabetes Res Clin Pract; 2017 Sep; 131():1-11. PubMed ID: 28666105
[TBL] [Abstract][Full Text] [Related]
7. L-165,041, troglitazone and their combination treatment to attenuate high glucose-induced receptor for advanced glycation end products (RAGE) expression.
Liang YJ; Jian JH; Chen CY; Hsu CY; Shih CY; Leu JG
Eur J Pharmacol; 2013 Sep; 715(1-3):33-8. PubMed ID: 23831394
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
9. PPARγ-PI3K/AKT-NO signal pathway is involved in cardiomyocyte hypertrophy induced by high glucose and insulin.
Peng X; Chen R; Wu Y; Huang B; Tang C; Chen J; Wang Q; Wu Q; Yang J; Qiu H; Jiang Q
J Diabetes Complications; 2015 Aug; 29(6):755-60. PubMed ID: 26045205
[TBL] [Abstract][Full Text] [Related]
10. Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-gamma activations in endothelial cells.
Nizamutdinova IT; Kim YM; Kim HJ; Seo HG; Lee JH; Chang KC
Atherosclerosis; 2009 Dec; 207(2):405-11. PubMed ID: 19524923
[TBL] [Abstract][Full Text] [Related]
11. Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic alpha-cell line.
Piro S; Maniscalchi ET; Monello A; Pandini G; Mascali LG; Rabuazzo AM; Purrello F
Endocrinology; 2010 Sep; 151(9):4197-206. PubMed ID: 20573722
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
[TBL] [Abstract][Full Text] [Related]
13. Insulin-sparing effects of troglitazone in rat pancreatic islets.
Bollheimer LC; Troll S; Landauer H; Wrede CE; Schölmerich J; Buettner R
J Mol Endocrinol; 2003 Aug; 31(1):61-9. PubMed ID: 12914525
[TBL] [Abstract][Full Text] [Related]
14. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.
Suga T; Kikuchi O; Kobayashi M; Matsui S; Yokota-Hashimoto H; Wada E; Kohno D; Sasaki T; Takeuchi K; Kakizaki S; Yamada M; Kitamura T
Mol Metab; 2019 Jan; 19():1-12. PubMed ID: 30416006
[TBL] [Abstract][Full Text] [Related]
15. Glucotoxicity and α cell dysfunction: involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal αTC1-6 cells.
Shen XX; Li HL; Pan L; Hong J; Xiao J; Hermansen K; Jeppesen PB; Li GW
Endocr Res; 2012; 37(1):12-24. PubMed ID: 22007944
[TBL] [Abstract][Full Text] [Related]
16. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
[TBL] [Abstract][Full Text] [Related]
17. Reversible inhibition of vasoconstriction by thiazolidinediones related to PI3K/Akt inhibition in vascular smooth muscle cells.
Sinagra T; Tamburella A; Urso V; Siarkos I; Drago F; Bucolo C; Salomone S
Biochem Pharmacol; 2013 Feb; 85(4):551-9. PubMed ID: 23194750
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells.
Solini A; Sebastiani G; Nigi L; Santini E; Rossi C; Dotta F
Diabetes Metab; 2017 Dec; 43(6):512-520. PubMed ID: 28499695
[TBL] [Abstract][Full Text] [Related]
19. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
Akinyeke TO; Stewart LV
Cancer Biol Ther; 2011 Jun; 11(12):1046-58. PubMed ID: 21525782
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
